PharmaCyte Biotech Initiates Studies to Confirm Its Pancreatic Cancer Therapy Can Treat Malignant Ascites

PharmaCyte Biotech, Inc. announced that it has initiated the first in a series of studies to test the ability of its pancreatic cancer therapy to treat malignant ascites.